Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.8600 (-0.79%) ($13.8400 - $13.8600) on Fri. May. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 68 | Latest Price | $13.8600(-0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 9.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.835% in a week (0% probabilities). VIXM(-22%) UUP(-14%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.11(-1.77%) | 10 Day Moving Average | $13.24(4.68%) | 20 Day Moving Average | $12.63(9.74%) | To recent high | -3.8% | To recent low | 46% | Market Cap | $2.445b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |